OCA at 12:28, 1 February 2024

OCA — Thu, 01 Feb 2024 12:28:29 GMT

←Older revision		Revision as of 12:28, 1 February 2024
Line 1:		Line 1:

-	====	+	==DARPin_D5/Her3 domain 4 complex, monoclinic crystals==
-	<StructureSection load='7bhe' size='340' side='right'caption='[[7bhe]]' scene=''>	+	<StructureSection load='7bhe' size='340' side='right'caption='[[7bhe]], [[Resolution\|resolution]] 2.30Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id= OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol= FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[7bhe]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7BHE OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7BHE FirstGlance]. <br>
-	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7bhe FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7bhe OCA], [https://pdbe.org/7bhe PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7bhe RCSB], [https://www.ebi.ac.uk/pdbsum/7bhe PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7bhe ProSAT]</span></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.297Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7bhe FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7bhe OCA], [https://pdbe.org/7bhe PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7bhe RCSB], [https://www.ebi.ac.uk/pdbsum/7bhe PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7bhe ProSAT]</span></td></tr>
	</table>		</table>
		+	== Disease ==
		+	[https://www.uniprot.org/uniprot/ERBB3_HUMAN ERBB3_HUMAN] Defects in ERBB3 are the cause of lethal congenital contracture syndrome type 2 (LCCS2) [MIM:[https://omim.org/entry/607598 607598]; also called Israeli Bedouin multiple contracture syndrome type A. LCCS2 is an autosomal recessive neurogenic form of a neonatally lethal arthrogryposis that is associated with atrophy of the anterior horn of the spinal cord. The LCCS2 syndrome is characterized by multiple joint contractures, anterior horn atrophy in the spinal cord, and a unique feature of a markedly distended urinary bladder. The phenotype suggests a spinal cord neuropathic etiology.<ref>PMID:17701904</ref>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/ERBB3_HUMAN ERBB3_HUMAN] Binds and is activated by neuregulins and NTAK.<ref>PMID:15358134</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	The members of the human epidermal growth factor receptor (HER) family are among the most intensely studied oncological targets. HER3 (ErbB3), which had long been neglected, has emerged as a key oncogene, regulating the activity of other receptors and being involved in progression and tumor escape in multiple types of cancer. Designed ankyrin-repeat proteins (DARPins) serve as antibody mimetics that have proven to be useful in the clinic, in diagnostics and in research. DARPins have previously been selected against EGFR (HER1), HER2 and HER4. In particular, their combination into bivalent binders that separate or lock receptors in their inactive conformation has proved to be a promising strategy for the design of potent anticancer therapeutics. Here, the selection of DARPins targeting extracellular domain 4 of HER3 (HER3d4) is described. One of the selected DARPins, D5, in complex with HER3d4 crystallized in two closely related crystal forms that diffracted to 2.3 and 2.0 A resolution, respectively. The DARPin D5 epitope comprises HER3d4 residues 568-577. These residues also contribute to interactions within the tethered (inactive) and extended (active) conformations of the extracellular domain of HER3.
		+
		+	Crystal structures of HER3 extracellular domain 4 in complex with the designed ankyrin-repeat protein D5.,Radom F, Vonrhein C, Mittl PRE, Pluckthun A Acta Crystallogr F Struct Biol Commun. 2021 Jul 1;77(Pt 7):192-201. doi: , 10.1107/S2053230X21006002. Epub 2021 Jun 29. PMID:34196609<ref>PMID:34196609</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 7bhe" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: ~~Z-disk~~]]	+	[[Category: Synthetic construct]]
		+	[[Category: Mittl PRE]]
		+	[[Category: Pluckthun A]]
		+	[[Category: Radom F]]

OCA at 12:33, 24 November 2021

OCA — Wed, 24 Nov 2021 12:33:21 GMT

←Older revision		Revision as of 12:33, 24 November 2021
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 7bhe ~~is ON HOLD until Paper Publication~~	+	====
-		+	<StructureSection load='7bhe' size='340' side='right'caption='[[7bhe]]' scene=''>
-	~~Authors~~:	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id= OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol= FirstGlance]. <br>
-	~~Description~~:	+	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7bhe FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7bhe OCA], [https://pdbe.org/7bhe PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7bhe RCSB], [https://www.ebi.ac.uk/pdbsum/7bhe PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7bhe ProSAT]</span></td></tr>
-	[[Category: ~~Unreleased~~ Structures]]	+	</table>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Large Structures]]
		+	[[Category: Z-disk]]

OCA at 06:31, 27 January 2021

OCA — Wed, 27 Jan 2021 06:31:12 GMT

←Older revision		Revision as of 06:31, 27 January 2021
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 7bhe is ON HOLD	+	The entry 7bhe is ON HOLD until Paper Publication

	Authors:		Authors:

OCA: Protected "7bhe" [edit=sysop:move=sysop]

OCA — Wed, 20 Jan 2021 06:40:09 GMT

Protected "7bhe" [edit=sysop:move=sysop]

←Older revision

Revision as of 06:40, 20 January 2021

OCA: New page: '''Unreleased structure''' The entry 7bhe is ON HOLD Authors: Description: Category: Unreleased Structures

OCA — Wed, 20 Jan 2021 06:40:08 GMT

New page: '''Unreleased structure''' The entry 7bhe is ON HOLD Authors: Description: Category: Unreleased Structures

New page

'''Unreleased structure'''

The entry 7bhe is ON HOLD

Authors:

Description:
[[Category: Unreleased Structures]]

7bhe - Revision history

OCA at 12:28, 1 February 2024

OCA at 12:33, 24 November 2021

OCA at 06:31, 27 January 2021

OCA: Protected "7bhe" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 7bhe is ON HOLD Authors: Description: Category: Unreleased Structures